Literature DB >> 8000740

Synovial fluid muramic acid in acute inflammatory arthritis.

L Lehtonen1, P Kortekangas, P Oksman, E Eerola, H Aro, A Toivanen.   

Abstract

Presence of muramic acid, a bacterial cell wall component, was analysed by gas chromatography-mass spectrometry in synovial fluid (SF) of 40 patients with acute inflammatory arthritis. SF muramic acid was observed in 4/14 patients with acute, culture negative inflammatory arthritis of unclear origin. Each of these four patients had a history of a recent bacterial disease (pansinuitis, purulent leg ulcer, erysipelas, unexplained fever with suspicion of cholecystitis and urinary tract infection). In the bacterial arthritis, SF muramic acid was detected in 6/12 patients (in 2/6 culture negative cases). In the reactive arthritis due to Salmonella or Yersinia, the rate of positivity was 2/14. Nineteen samples of traumatic SF effusion were muramic acid negative. These findings indicate that several cases of undefined acute inflammatory arthritis are of bacterial origin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8000740     DOI: 10.1093/rheumatology/33.12.1127

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  9 in total

Review 1.  Two forms of reactive arthritis?

Authors:  P Toivanen; A Toivanen
Journal:  Ann Rheum Dis       Date:  1999-12       Impact factor: 19.103

Review 2.  How can a causal role for small bacteria in chronic inflammatory arthritides be established or refuted?

Authors:  D Taylor-Robinson; A Keat
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

Review 3.  Normal intestinal microbiota in the aetiopathogenesis of rheumatoid arthritis.

Authors:  P Toivanen
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

4.  [Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative].

Authors:  I H Tarner; K Albrecht; M Fleck; E Gromnica-Ihle; G Keyßer; L Köhler; I Kötter; K Krüger; J Kuipers; H Nüßlein; A Rubbert-Roth; J Wollenhaupt; M Schneider; B Manger; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2014-05       Impact factor: 1.372

5.  Muramic acid is not generally present in the human spleen as determined by gas chromatography-tandem mass spectrometry.

Authors:  Michael P Kozar; Jon D Laman; Alvin Fox
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

6.  Influence of major histocompatibility complex on bacterial composition of fecal flora.

Authors:  P Toivanen; J Vaahtovuo; E Eerola
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

7.  Failure To detect muramic acid in normal rat tissues but detection in cerebrospinal fluids from patients with Pneumococcal meningitis.

Authors:  M P Kozar; M T Krahmer; A Fox; B M Gray
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

8.  Absolute identification of muramic acid, at trace levels, in human septic synovial fluids in vivo and absence in aseptic fluids.

Authors:  A Fox; K Fox; B Christensson; D Harrelson; M Krahmer
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

9.  Enzyme degradation and proinflammatory activity in arthritogenic and nonarthritogenic Eubacterium aerofaciens cell walls.

Authors:  X Zhang; M Rimpiläinen; E Simelyte; P Toivanen
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.